|

What’s most important to markets right now? Vaccines

The news last week that Johnson and Johnson’s vaccine caused blood clots sent a shiver down markets mid-week. However, once the headline was digested it was realized that there were still vaccine alternatives to replace J&J’s even if there was a delay in the rollout.

White house confirms vaccine coverage

This was underlined by White House COVID Coordinator Zients who stated last week that there is plenty of vaccine supply in the system, even without J&J’s COVID-19 vaccine and that the US Gov’t is doing everything it can to accelerate the Pfizer and Moderna vaccines.

Ok, panic over. The dip was bought on the headline last week.

However, it is interesting to note that in stark contrast to the inflation fears, which came to nothing last week, the market remains laser-focused on the vaccine rollout. So, right now, vaccines matter most.

One interesting headline from last week that could be lost in the mix is the fact that Novavax will be taking part in an Oxford University study comparing mixed COVID-19 vaccine combinations from different manufacturers. The idea of the study is to explore any potential possibility there is of mixing doses. This will be extremely helpful if a ‘mix&max’ combination is possible and should help speed up the vaccination process and reward manufacturers who can supply the most quickly. One report to look out for as it could give risk assets a positive boost if the study proves positive. The current levels of people who have received at least one vaccine can be seen here below. 

Vaccine

The key impact of any significant delay/problem in the vaccination program would be a sell-off in equity markets.

SP500

Learn more about HYCM

Author

Giles Coghlan LLB, Lth, MA

Giles is the chief market analyst for Financial Source. His goal is to help you find simple, high-conviction fundamental trade opportunities. He has regular media presentations being featured in National and International Press.

More from Giles Coghlan LLB, Lth, MA
Share:

Editor's Picks

AUD/USD sits at fresh 10-month lows, nears 0.6700

AUD/USD refreshes ten-month lows below 0.6750 and approaches 0.6700 in Wednesday’s Asian session. Fed rate-hike bets, along with fresh exchange of fire between the US and Iran, underpin the safe-haven US Dollar. Furthermore, the RBA’s dovish tilt weighs on the Aussie and the pair.

USD/JPY defends bids near 159.50 on hawkish BoJ Ueda

USD/JPY is defending bids near 159.50 in the Asian session on Wednesday, holding a three-day losing streak after hawkish commentary from BoJ Governor Ueda supports the Japanese Yen amid looming intervention risks. Meanwhile, escalating Middle East tensions revive US Dollar demand amid hawkish Fed bets, which could limit the pair's downside.



Gold stays week below $3,800 as traders look to FOMC Minutes for Fed rate cues

Gold sticks to intraday losses below the $3,800 mark through the early European session, trading near its lowest level since September 2025, which it touched this Wednesday. Following last week’s hot US inflation reports, several Federal Reserve officials adopted a more hawkish tone and signaled further interest-rate hikes. Adding to this, Tuesday’s upbeat US data cemented market bets, which continue to act as a tailwind for the US Dollar, and drive flows away from non-yielding bullion.

Dogecoin stuck in bearish trend after new lows

Dogecoin remains under pressure, trading around $0.059 on Wednesday, struggling to recover from last week’s sharp sell-off that pushed the meme coin to a new yearly low of $0.055. Weakening derivatives activity and bearish on-chain metrics continue to weigh on market sentiment.

Nvidia offers up double beat in third quarter

Nvidia (NVDA) shares jumped 3% afterhours as the leading AI chipmaker easily surpassed Wall Street's projections for the third quarter. The semiconductor powerhouse posted adjusted earnings per share of $2.68, 8.5% or $0.21 better than the consensus. Revenue of $115.85 billion clobbered the consensus by $7.1 billion or 6.6%.

Gold isn't being sold for thew reason most people think
Gold (XAU/USD) remains under heavy selling pressure on Monday, hitting its lowest level in 13 months. The precious metal is struggling to recover despite escalating geopolitical tensions in the Middle East, a backdrop that would normally encourage investors to seek protection in safe-haven assets. However, the main driver behind Gold's decline is not the geopolitical uncertainty itself.